Literature DB >> 15506520

Neural reapportionment: an hypothesis to account for the function of sleep.

Joseph A Gally1, Gerald M Edelman.   

Abstract

Sleep is a ubiquitous component of animal life, and prolonged sleep deprivation is fatal in both vertebrates and invertebrates. The physiologic function of sleep, however, is not known. We propose here that sleep provides a period of time necessary to reapportion resources within neurons and neural systems that become sub-optimally distributed during active waking. Three specific examples of such reapportionment during sleep are suggested: (1) the return of the neurotransmitter, glutamate, to synaptic vesicles at presynaptic sites most active during waking, (2) the intracellular movement of mitochondria from neuronal processes to the cells soma where mitochondrial replication can occur, and (3) the readjustment of the level and distribution of neurotransmitters within the brainstem modulatory systems and elsewhere that must function in an integrated fashion during waking. Experimental approaches that might be utilized to test these hypotheses are suggested.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506520     DOI: 10.1016/j.crvi.2004.05.009

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  3 in total

1.  A quantitative, theoretical framework for understanding mammalian sleep.

Authors:  Van M Savage; Geoffrey B West
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

Review 2.  Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

Authors:  Michael J Maher; Simon A Rego; Gregory M Asnis
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Plasticity and Susceptibility of Brain Morphometry Alterations to Insufficient Sleep.

Authors:  Xi-Jian Dai; Jian Jiang; Zhiqiang Zhang; Xiao Nie; Bi-Xia Liu; Li Pei; Honghan Gong; Jianping Hu; Guangming Lu; Yang Zhan
Journal:  Front Psychiatry       Date:  2018-06-27       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.